Improvement in oxygenation with a calcium channel blocker in a patient with hepatopulmonary syndrome during tacrolimus therapy following living donor liver transplantation - A case report

Improvement in oxygenation with a calcium channel blocker in a patient with hepatopulmonary syndrome during tacrolimus therapy following living donor liver transplantation - A case report

Saved in:

Bibliographic Details
Main Authors:	Tatsumi Yakushiji, Jun Honda, Atsuyuki Hosono, Satoki Inoue
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Series:	Indian Journal of Anaesthesia
Online Access:	https://journals.lww.com/10.4103/ija.ija_952_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of Calcium Ion, Calpains, and Calcium Channel Blockers on Retinitis Pigmentosa
by: Mitsuru Nakazawa
Published: (2011-01-01)

Interfacility Transfer for VA-ECMO in Beta Blocker and Calcium Channel Blocker Overdoses: A Report of Two Cases
by: Richard Fisher, et al.
Published: (2025-01-01)

Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?
by: Omer Faruk BAYCAN, et al.
Published: (2023-03-01)

Navigating a complicated liver transplant in a patient with severe hepatopulmonary syndrome without extracorporeal membrane oxygenation: a case report
by: Steffi Kang Ting Chan, et al.
Published: (2023-08-01)

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
by: Yuwen Sheng, et al.
Published: (2025-01-01)

Impact of donor CYP3A5 genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients
by: C Wheeler, et al.
Published: (2024-04-01)

Cerebrovascular Accidents After Orthotopic Liver Transplantation in Patients with Hepatopulmonary Syndrome: A Case Series
by: Steffi K. Chan, et al.
Published: (2024-12-01)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
by: Yutaka Kawabata, et al.
Published: (2020-01-01)

The Relationship Between Hepatopulmonary Syndrome and Altitude
by: Morgan A Valley, et al.
Published: (2014-01-01)

Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
by: Kazuomi Kario, et al.
Published: (2025-01-01)

The Successful Use of Inhaled Nitric Oxide in the Management of Severe Hepatopulmonary Syndrome after Orthotopic Liver Transplantation
by: Joshua Santos, et al.
Published: (2014-01-01)

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01)

Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
by: Julián Alejandro Rivillas, et al.
Published: (2021-01-01)

Evaluation of efficacy and safety of generic tacrolimus (Suprotac®) compared to reference tacrolimus (Prograf<sup>®</sup>) in kidney transplantation: a phase IV study
by: Behzad Einollahi, et al.
Published: (2025-01-01)

Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies
by: Sevak Hatamian, et al.
Published: (2025-06-01)

The Role of TEE in Diagnosing Hepatopulmonary Syndrome and Cryptogenic Cirrhosis
by: Joel Scott-Herridge, et al.
Published: (2016-01-01)

Novel ecofriendly spectrophotometric methods for the determination of six dihydropyridines calcium channel blockers through derivatization with sulfophtalein dye: application to tablet analysis
by: Mariana Horyn, et al.
Published: (2025-01-01)

Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient
by: Samuel Chan, et al.
Published: (2017-01-01)

Tacrolimus trough level and oxidative stress in Tunisian kidney transplanted patients
by: Mariam Ammar, et al.
Published: (2024-12-01)

Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
by: Fernando González, et al.
Published: (2017-01-01)

The association between serum tacrolimus concentrations and BK viruria in kidney transplant recipients
by: Napatsorn Kraivisitkul, et al.
Published: (2025-01-01)

Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
by: Radhika Zopey, et al.
Published: (2013-01-01)

Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients
by: Alan D. Kaye, et al.
Published: (2024-12-01)

Limitations of high-frequency variability index in pain monitoring during pheochromocytoma resection
by: Jun Honda, et al.
Published: (2024-10-01)

Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin
by: Céline Hivelin, et al.
Published: (2016-01-01)

Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome
by: Fabien Robert, et al.
Published: (2025-03-01)

Estimation of serum calcium levels in apheresis platelet donors
by: P. Arpitha, et al.
Published: (2024-01-01)

Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report
by: Ahmad Matarneh, et al.
Published: (2025-02-01)

Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial
by: Manisha Verma, et al.
Published: (2023-01-01)

A Prospective Study to Assess the Best Optimal Dose of Tacrolimus before Renal Transplantation and Its Impact on Graft Survival and Patient Outcome in Renal Transplant Recipients
by: Niranjan Gogoi, et al.
Published: (2024-12-01)

Haploidentical Family Donor Transplantation: At the Crossroads of a Changing Paradigm
by: Suparno Chakrabarti, et al.
Published: (2016-01-01)

Manic-Like Psychosis Associated with Elevated Trough Tacrolimus Blood Concentrations 17 Years after Kidney Transplant
by: Giuseppe Bersani, et al.
Published: (2013-01-01)

Impact of Tacrolimus, Sirolimus, Age, and Body Mass Index on the Occurrence of Skin Cancer and Islet Dysfunction After Transplantation
by: Christopher Orr, et al.
Published: (2025-01-01)

The hope as social commitment in the processing of tacrolimus
by: Alessandra Suzin Bertan, et al.
Published: (2020-10-01)

Adult-to-Adult Living Donor Liver Transplantation
by: Shimul A Shah, et al.
Published: (2006-01-01)

Renal Transplantation from Elderly Living Donors
by: Jacob A. Akoh, et al.
Published: (2013-01-01)

Liver Transplant From a Deceased Donor With Cystinosis: A Case Report
by: Raeda Taj, et al.
Published: (2025-01-01)

Is Bigger Better? Living Donor Kidney Volume as Measured by the Donor CT Angiogram in Predicting Donor and Recipient eGFR after Living Donor Kidney Transplantation
by: Chaudhry Adeel Ebad, et al.
Published: (2021-01-01)

Synthesis and Spectroscopic and Biological Activities of Zn(II) Porphyrin with Oxygen Donors
by: Gauri Devi Bajju, et al.
Published: (2014-01-01)

Granulosis Rubra Nasi Response to Topical Tacrolimus
by: Farhana Tahseen Taj, et al.
Published: (2017-01-01)